Position in EQ
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$6,705,674
+$3,037,308 QoQ
Shares Held
3,352,837
+41.7% QoQ
Ownership
5.30%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,721,223,490 across 84 Biotechnology names. EQ ranks #61 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 4 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 5 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
2,318,890 | $50,459,046 |
All Filings in EQ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-04-01 | $6,839,787 | 3,352,837 | Shares | Sole | 2026-05-07 | |
| 2026-03-31 | $6,705,674 | 3,352,837 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $3,668,366 | 2,366,688 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $542,722 | 379,526 | Shares | Defined | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||